Clinical Study Data Request Registered Users, Please Login

Scroll down the list of studies provided below. Studies are listed by study medicine in alphabetical order. Alternatively you can browse the list of studies using the search function.

To select studies and submit a research proposal or enquiry, go back to the Home page and select View and submit.

This takes you back to the previous page to enable you to view studies from a different sponsor.

Select medicine, medical condition or phase from the drop down boxes. This searches all the available clinical studies. Selecting from more than one drop down box will “and” the criteria.

Find by:


Alternatively search for studies using the GSK Clinical Study Identification Number or study title by entering text and clicking search.

 

2071 found

Click the study title to find more information about the study.

GSK-APP116480
An open label, balanced, randomized, three-treatment, three-period, six-sequence, cross-over, single dose, comparative bioavailability pilot study of two test formulations of fixed dose combination capsules of acetylsalicylic acid (ASA) and pantoprazole (Each capsule contains ASA 100 mg and pantoprazole 20 mg) manufactured by Piramal Healthcare Limited, India for GSK comparing with Aspirin® Protect 100 mg tablets by Bayer vital GmbH, and Protium® 20 mg gastro-resistant tablets by Nycomed GmbH, in healthy, a
GSK-APP116498
An open label, balanced, randomized, three-treatment, three-period, six-sequence, cross-over, single dose, comparative bioavailability pilot study of two test formulations of fixed dose combination capsules of acetylsalicylic acid (ASA) and pantoprazole (Each capsule contains ASA 100 mg and pantoprazole 20 mg) manufactured by Piramal Healthcare Limited, India for GSK comparing with Aspirin® Protect 100 mg tablets by Bayer vital GmbH, and Protium® 20 mg gastro-resistant tablets by Nycomed GmbH, in healthy, a
GSK-LAF114957
A Randomized, Open-label, Single-dose, Two-period, Crossover Study to Demonstrate the Bioequivalence of the Fixed Dose Combination (FDC) of lamivudine and adefovir dipivoxil (100mg/10mg) to Heptodin® (100mg ) and Hepsera® (10mg)

Medicine: adefovir/lamivudine, Condition: Hepatitis B, Chronic, Phase: 1, Clinical Study ID: LAF114957, Sponsor: GSK
GSK-GLP108370
An adaptive design study for the assessment of the pharmacokinetics of albiglutide in subjects with normal renal function and subjects with moderate-to-severe renal impairment and hemodialysis.

Medicine: albiglutide, Condition: Diabetes Mellitus, Type 2, Phase: 1, Clinical Study ID: GLP108370, Sponsor: GSK
GSK-GLP106073
A single-blinded randomized, placebo-controlled, staggered-parallel, escalating-dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in Subjects with type 2 Diabetes Mellitus

Medicine: albiglutide, Condition: Diabetes Mellitus, Type 2, Phase: 2, Clinical Study ID: GLP106073, Sponsor: GSK
GSK-GLP107030
A Single-Blind, Randomized, Placebo-Controlled Study in Healthy Men and Women to Determine the Effect of Single Subcutaneous Injections of GSK716155 on Gastric Emptying Time for Solid and Liquid Components of a Meal

Medicine: albiglutide, Condition: Diabetes Mellitus, Type 2, Phase: 1, Clinical Study ID: GLP107030, Sponsor: GSK
GSK-GLP105229
A double-blinded, randomized, placebo-controlled, staggered-parallel, escalating dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in healthy volunteers.

Medicine: albiglutide, Condition: Diabetes Mellitus, Type 2, Phase: 1, Clinical Study ID: GLP105229, Sponsor: GSK
GSK-GLP107032
An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects

Medicine: albiglutide, Condition: Diabetes Mellitus, Type 2, Phase: 1, Clinical Study ID: GLP107032, Sponsor: GSK
GSK-GLP107085
A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin)

Medicine: albiglutide, Condition: Diabetes Mellitus, Type 2, Phase: 1, Clinical Study ID: GLP107085, Sponsor: GSK
GSK-GLP111680
An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Albiglutide in Healthy Adult Subjects

Medicine: albiglutide, Condition: Diabetes Mellitus, Type 2, Phase: 1, Clinical Study ID: GLP111680, Sponsor: GSK
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Next Last